Evidence map›Paper›PMID 15925202›Full record

ArticleHearing research2005

TRPV1 regulators mediate gentamicin penetration of cultured kidney cells.

Sigrid E Myrdal, Peter S Steyger

Abstract read
In one paragraph

Article in Hearing research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Identifying targets to prevent aminoglycoside ototoxicity.Molecular and cellular neurosciences · 2022
    Review
  8. Article
  9. Mechanisms of Ototoxicity and Otoprotection.Otolaryngologic clinics of North America · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sigrid E MyrdalOregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Peter S Steyger
Oregon Health & Science University · US

Funding

PORTLAND AREA COMMUNICATION RESEARCH CORE CENTERP30DC005983 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI NUTTALL, ALFRED L · 2003 to 2017
$9.0M
HAIR CELL RESPONSES TO OTOTOXIC DRUGSR01DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2001 to 2020
$6.6M
Hair cell responses to ototoxic drugsR56DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2007 to 2007
$385k
Functional similarities in renal and cochlear epitheliaR21DC006084 · NIDCD · OREGON HEALTH AND SCIENCE UNIVERSITY · PI STEYGER, PETER S · 2003 to 2004
$299k
NIDCD NIH HHS DC04555NIDCD NIH HHS DC06084NIDCD NIH HHS P30 DC005983NIDCD NIH HHS R01 DC004555NIDCD NIH HHS R21 DC006084
6 · The paper itself

Abstract

Transient receptor potential (TRP) receptors are, typically, calcium-permeant cation channels that transduce environmental stimuli. Both kidney epithelial and inner ear sensory cells express TRPV1, are mechanosensors and accumulate the aminoglycoside antibiotic gentamicin. Recently, we showed that Texas Red-conjugated gentamicin (GTTR) enters kidney cells via an endosome-independent pathway. Here, we used GTTR to investigate this non-endocytotic mechanism of gentamicin uptake. In serum-free buffers, GTTR penetrated MDCK cells within 30 s and uptake was modulated by extracellular, multivalent cations (Ca2+, La3+, Gd3+) or protons. We verified the La3+ modulation of GTTR uptake using immunocytochemical detection of unconjugated gentamicin. Membrane depolarization, induced by high extracellular K+ or valinomycin, also reduced GTTR uptake, suggesting electrophoretic permeation through ion channels. GTTR uptake was enhanced by the TRPV1 agonists, resiniferatoxin and anandamide, in Ca2+-free media. Competitive antagonists of the TRPV1 cation current, iodo-resiniferatoxin and SB366791, also enhanced GTTR uptake independently of Ca2+, reinforcing these antagonists' potential as latent agonists in specific situations. Ruthenium Red blocked GTTR uptake in the presence or absence of these TRPV1-agonists and antagonists. In addition, GTTR uptake was blocked by RTX in the presence of more physiological levels (2 mM) of Ca2+. Thus gentamicin enters cells via cation channels, and gentamicin uptake can be modulated by regulators of the TRPV1 channel.

Indexed as

AnilidesAnimalsAnti-Bacterial AgentsArachidonic AcidsCalciumCalcium Channel BlockersCell LineCinnamatesDiterpenesDogsEndocannabinoidsFluorescent DyesGadoliniumGentamicinsHydrogen-Ion ConcentrationIndicators and ReagentsanandamideAnilidesAnti-Bacterial AgentsArachidonic AcidsCalciumCalcium Channel BlockersCinnamatesDiterpenesEndocannabinoidsFluorescent DyesGadoliniumGentamicinsIndicators and ReagentsiodoresiniferatoxinIonophoresLanthanumN-(3-methoxyphenyl)-4-chlorocinnamanilidePolyunsaturated AlkamidesresiniferatoxinRuthenium RedTexas redTRPV1 receptorTRPV Cation ChannelsValinomycinXanthenes

Identifiers

PMID15925202
PMCPMC2736064
OpenAlexW1978195237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.